Switch to:
More From Other Websites
Shire Submits NDA for Dry Eye Disease Drug Lifitegrast - Analyst Blog Mar 05 2015
Oncolytics' Reolysin Gets Orphan Drug Status Yet Again - Analyst Blog Mar 04 2015
Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog Mar 03 2015
Halozyme Q4 Loss Narrower-than-Expected, Revenues Up - Analyst Blog Mar 03 2015
Biogen/Sobi Report Postive Phase III Data on Alprolix - Analyst Blog Mar 02 2015
Amgen's Kyprolis Under EU Review - Analyst Blog Feb 28 2015
Actavis' Infectious Disease Product, Avycaz, Gets FDA Nod - Analyst Blog Feb 26 2015
Medivation Beats on Q4 Earnings & Revenues; Xtandi Soars - Analyst Blog Feb 26 2015
Integra Lifesciences Tops Q4 Earnings, Revenues; Up Y/Y - Analyst Blog Feb 25 2015
China Biologic Products CBPO) Falls: Stock Goes Down 6% - Tale of the Tape Feb 25 2015
Exact Sciences (EXAS) Falls: Stock Goes Down 5.6% - Tale of the Tape Feb 24 2015
Innovation Alive And Well In Medical-Products Group Feb 19 2015
Will Cambrex (CBM) Continue to Surge Higher? - Tale of the Tape Feb 19 2015
Oncolytics' Reolysin Gets Another Orphan Drug Status - Analyst Blog Feb 18 2015
Zacks Rank #1 Additions for Wednesday - Tale of the Tape Feb 18 2015
Increased Earnings Estimates Seen for Cambrex Corporation (CBM): Can It Move Higher? - Tale of the... Feb 18 2015
CAMBREX CORP Financials Feb 12 2015
4 Top Stocks to Buy on Earnings Beats and Raised Guidance Feb 10 2015
Cambrex (CBM) Worth Watching: Stock Soars 27.5% - Tale of the Tape Feb 09 2015
10-K for Cambrex Corp. Feb 08 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial